Cargando…

Bone metabolism in patients with type 1 neurofibromatosis: key role of sun exposure and physical activity

Bone metabolism has been rarely investigated in children affected by Neurofibromatosis type 1 (NF1). Aim of the present study was to assess bone mineral metabolism in children and adults NF1 patients, to determine the relevant factors potentially involved in the development of reduced bone mineral d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrara, Ursula Pia, Tortora, Cristina, Rosano, Carmen, Assunto, Antonia, Rossi, Alessandro, Pagano, Stefano, Falco, Mariateresa, Simeoli, Chiara, Ferrigno, Rosario, D’Amico, Alessandra, Di Salvio, Dario, Cangemi, Giuliana, Pivonello, Rosario, Strisciuglio, Pietro, Melis, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921306/ https://www.ncbi.nlm.nih.gov/pubmed/35288591 http://dx.doi.org/10.1038/s41598-022-07855-4

Ejemplares similares

Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1
por: Assunto, Antonia, et al.
Publicado: (2019)

Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement
por: Rossi, Alessandro, et al.
Publicado: (2020)

SUN-358 Dual Release Hydrocortisone as a New Treatment for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Simeoli, Chiara, et al.
Publicado: (2019)

Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia
por: Rossi, Alessandro, et al.
Publicado: (2023)

RASopathies and hemostatic abnormalities: key role of platelet dysfunction
por: Di Candia, Francesca, et al.
Publicado: (2021)

Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant
por: Pivonello, Rosario, et al.
Publicado: (2022)

Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
por: Pivonello, Rosario, et al.
Publicado: (2020)

Cushing’s disease: adrenal steroidogenesis inhibitors
por: Pivonello, Rosario, et al.
Publicado: (2022)

SUN-463 Tumor Shrinkage with Preoperative Relacorilant Therapy in Two Patients with Cushing Disease Due to Pituitary Macroadenomas
por: Terzolo, Massimo, et al.
Publicado: (2019)

Ontología y teleología del jardín
por: Assunto, Rosario
Publicado: (1991)

Naturaleza y razón en la estética del setecientos /
por: Assunto, Rosario
Publicado: (1989)

Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit
por: Provvisiero, Donatella Paola, et al.
Publicado: (2019)

Retrospective Multicentric Study on Non-Optic CNS Tumors in Children and Adolescents with Neurofibromatosis Type 1
por: Santoro, Claudia, et al.
Publicado: (2020)

Influence of Bisphenol A on Type 2 Diabetes Mellitus
por: Provvisiero, Donatella Paola, et al.
Publicado: (2016)

Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature
por: Simeoli, Chiara, et al.
Publicado: (2022)

Medullary unidentified bright objects in Neurofibromatosis type 1: a case series
por: D’Amico, Alessandra, et al.
Publicado: (2018)

The role of mTOR pathway as target for treatment in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

Endocrine system involvement in patients with RASopathies: A case series
por: Siano, M. A., et al.
Publicado: (2022)

COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
por: Pivonello, Rosario, et al.
Publicado: (2020)

The treatment with pasireotide in Cushing’s disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single center
por: Simeoli, C., et al.
Publicado: (2019)

Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome
por: D’Amico, Alessandra, et al.
Publicado: (2020)

The dopaminergic control of Cushing’s syndrome
por: Pivonello, R., et al.
Publicado: (2022)

Neuropsychiatric disorders in Cushing's syndrome
por: Pivonello, Rosario, et al.
Publicado: (2015)

Vitamin D Reverts the Exosome-Mediated Transfer of Cancer Resistance to the mTOR Inhibitor Everolimus in Hepatocellular Carcinoma
por: Negri, Mariarosaria, et al.
Publicado: (2022)

Glucocorticoid excess and COVID-19 disease
por: Guarnotta, Valentina, et al.
Publicado: (2020)

A UHPLC–MS/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots
por: Pigliasco, Federica, et al.
Publicado: (2021)

The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma
por: Pivonello, Claudia, et al.
Publicado: (2016)

Neurofibromatosis and HIV infection in a pregnant woman
por: Pepe, Franco, et al.
Publicado: (2021)

Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool
por: Minnetti, Marianna, et al.
Publicado: (2022)

Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
por: Santoro, Claudia, et al.
Publicado: (2018)

The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
por: Colao, Annamaria, et al.
Publicado: (2015)

Approach to the Patient With Prolactinoma
por: Auriemma, Renata S, et al.
Publicado: (2023)

Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype–Phenotype Correlations
por: Peduto, Cristina, et al.
Publicado: (2023)

Sex and gender differences in community-acquired pneumonia
por: Corica, Bernadette, et al.
Publicado: (2022)

Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature
por: Di Candia, Francesca, et al.
Publicado: (2021)

Neurofibromatosis
por: Gerber, PA, et al.
Publicado: (2009)

Neurofibromatosis
por: Hovinga, Koos E., et al.
Publicado: (2020)

Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
por: Pivonello, Claudia, et al.
Publicado: (2022)

Testis-Specific Genes Deregulation in the Testis of COVID-19 Patients: A Potential Driver of Spermatogenesis Disruption?
por: Pivonello, Rosario, et al.
Publicado: (2022)

Prevalence, Type, and Molecular Spectrum of NF1 Mutations in Patients with Neurofibromatosis Type 1 and Congenital Heart Disease
por: Pinna, Valentina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u2n1kamvea3lvcu8j4u9fqn1qa